Nanocarrier cancer therapeutics with functional stimuli-responsive mechanisms

J Nanobiotechnology. 2022 Mar 24;20(1):152. doi: 10.1186/s12951-022-01364-2.

Abstract

Presently, nanocarriers (NCs) have gained huge attention for their structural ability, good biocompatibility, and biodegradability. The development of effective NCs with stimuli-responsive properties has acquired a huge interest among scientists. When developing drug delivery NCs, the fundamental goal is to tackle the delivery-related problems associated with standard chemotherapy and to carry medicines to the intended sites of action while avoiding undesirable side effects. These nanocarriers were able of delivering drugs to tumors through regulating their pH, temperature, enzyme responsiveness. With the use of nanocarriers, chemotherapeutic drugs could be supplied to tumors more accurately that can equally encapsulate and deliver them. Material carriers for chemotherapeutic medicines are discussed in this review keeping in viewpoint of the structural properties and targeting methods that make these carriers more therapeutically effective, in addition to metabolic pathways triggered by drug-loaded NCs. Largely, the development of NCs countering to endogenous and exogenous stimuli in tumor regions and understanding of mechanisms would encourage the progress for tumor therapy and precision diagnosis in future.

Keywords: Cancer therapy; Functional nanocarriers; Smart drug delivery; Stimulus-responsive drug release.

Publication types

  • Review

MeSH terms

  • Drug Carriers / chemistry
  • Drug Delivery Systems
  • Humans
  • Nanoparticles* / chemistry
  • Neoplasms* / drug therapy
  • Temperature

Substances

  • Drug Carriers